Tute Genomics, a bioinformatics software developer backed by Tencent, Intermountain Healthcare and Wilmington Pharmatech, has been bought for an undisclosed sum.
Internet group Tencent and healthcare system Intermountain Healthcare have exited US-based genomics software developer Tute Genomics in an acquisition by genomic analysis company PierianDx, which paid an undisclosed amount.
Founded in 2012, Tute Genomics has developed a bioinformatics software platform, and its constitutional and exome testing capabilities will be added to PierianDx’s offering post-acquisition.
Ted Briscoe, chief executive of PierianDx, said: “The enhanced platform will provide labs with a single clinical solution to support a comprehensive range of molecular testing…
